Although not being the ideal drug due to its low solubility and high toxicity, the benznidazole is the drug currently chosen for Chagas disease treatment. The deep knowledge about the characteristics of the drug in addition to the knowledge of more effective vectorization techniques of drugs in pharmaceutical forms allows a faster and cheaper development of a new therapeutic alternative in comparison to the introduction of a new molecule in the treatment. The aim of this study is the characterization of inclusion complexes Benznidazole and cyclodextrins in solid state. The interactions between Benznidazole (BNZ) and β-cyclodextrins (β-CD) modified: randomly methylated β-CD (RMβCD) and sulfobutylether β-CD (SBβCD) were studied by differential scanning calorimetry (DSC), fourier transform-infrared spectroscopy, RAMAN, and scanning electron microscopy. The preparation of solid-state binary systems by different techniques, namely, kneading, evaporated, and freeze-drying. The results suggest the formation of inclusion complexes of the drug with both CDs types in solid state by the techniques which were used, based on physicochemical data of interaction compared to the drug or the CDs/drug physical mixture. Thus, the preparation technique played an important role in the BNZ and modified CDs.
1. Coura, JR, Castro, SL 2002 A critical review on chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97:03–24 .
2. Lamas, MC, Villagi, L, Nocito, I, Bassani, G, Leonardi, D, Pascutti, F, Serra, E, Salomón, CJ 2006 Development of parenteral formulations and evaluations of the biological activity of the trypanocide drug benznidazole. Int J Pharm 307:239–243 .
3. Docampo, R 2001 Recent developments in the chemotherapy of Chagas disease. Curr Pharm Des 7:1157–1164 .
4. Morilla, MJ, Montanari, JA, Prieto, MO, Lopez, MO, Petray, PB, Romero, EL 2004 Intravenous liposomalbenznidazole as trypanocidal agent: increasing drug delivery to liver is not enough. Int J Pharm 278:311–318 .
5. Silva-Nogueira, S, Jerley, J, Pavanelli, WR, Gutierrez, FRS, Lima, FCA, Silva, ABF, Silva, SJ, Franco, WD 2008 Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy. J Med Chem 51:4104–4114 .
6. Jung, J, Yoo, S, Lee, S, Kim, K, Yoon, D, Lee, K 1999 Enchanced solubility and dissolution rates of itraconazole by a solid dispersion technique. Int J Pharm 187:195–201 .
7. Akkar, A, Muller, RH 2003 Intarvenous itraconazole emulsions produced by solemuls technology. Eur J Pharm Biopharm 56:29–36 .
8. Figueiras, A, Carvalho, RA, Ribeiro, L, Torres-Labandeira, JJ, Veiga, FJB 2007 Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm 67:531–539 .
9. Rodriguez-Tenreiro, C, Alvarez-Lorenzo, C, Concheiro, A, Torres-Labandeira, JJ 2004 Characterization of cyclodextrin–carbopol interactions by DSC and FTIR. J Therm Anal Calorim 77:403–411 .
10. Piel, G, Pirotte, B, Delneuville, I, Neven, P, Llabres, G, Delarge, J, Delattre, L 1997 Study of the influence of both cyclodextrins and l-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-l-lysine–cyclodextrin complexes. J Pharm Sci 86:475–480 .
11. Ventura, CA, Giannone, I, Paolino, D, Pistara, V, Corsaro, A, Puglisi, G 2005 Preparation of celecoxib-dimethyl-b-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur J Med Chem 40:624–631 .
12. Bruni, G, Milanese, C, Berbenni, V, Sartor, F, Villa, M, Marini, A 2010 Crystalline and amorphous phases of a new drug. J Therm Anal Calorim 102:297–303 .
13. Pinto, MF, Moura, EA, Souza, FS, Macêdo, RO 2010 Thermal compatibility studies of nitroimidazoles and excipients. J Therm Anal Calorim 102:323–329 .
14. Soares-Sobrinho, JL, Silva, ALM, Grangeiro-Júnior, S, Medeiros, FPM, Rolim-Neto, PJ 2006 Desenvolvimento e validação do método analítico para o doseamento de benznidazol. Rev Bras Farm 87:78–80.
15. Lipkowitz, KB 1998 Applications of computational chemistry to the study of cyclodextrins. Chem Rev 5:1829–1873 .
16. Pose-Vilarnovo, B, Perdomo-Lopez, I, Echezarreta-Lopez, M, Schroth-Pardo, P, Estrada, E, Torres-Labandeira, JJ 2001 Improvement of water solubility of sulfamethizole through its complexation with b- and hydroxypropyl-b-cyclodextrin. Characterization of the interaction in solution and in solid state. Eur J Pharm Sci 13:325–331 .
17. Hedges, AR 1998 Industrial applications of cyclodextrins. Chem Rev 98:2035–2044 .
18. Okimoto, K, Rajewski, RA, Uekama, K, Jona, JA, Stella, VJ 1996 The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins. Pharm Res 13:256–264 .
19. Fernandes, CM, Vieira, TM, Veiga, FJB 2002 Physicochemical characterization and in vitro dissolution behavior of nicardipine–cyclodextrins inclusion compounds. Eur J Pharm Sci 15:79–88 .
20. Cirri, M, Rangoni, C, Maestrelli, F, Corti, G, Mura, P 2005 Development of fast-dissolving tablets of flurbiprofen–cyclodextrin complexes. Drug Dev Ind Pharm 31:697–707 .
21. Soares-Sobrinho, JL, Cunha-Filho, MSS, Rolim-Neto, PJ, Torres-Labandeira, JJ, Dacunha-Marinho, B 2008 Benznidazole. Acta Cryst E64:o634.